In 2021, biotech companies account for 44% of the life sciences companies in South Korea. More than half of South Korean biotechs are part of the therapeutics and diagnostics sector, of which 19% are publicly listed on the stock exchange. The total value of venture financing for South Korean life sciences companies dropped by around … Continue reading South Korea Life Science Trend Analysis 2022
Category: South Korea
Yearly Life Sciences Reports of South Korea
Korean Life Science Market Trend Analysis 2020
South Korea is one of the most active life science markets in the world. In 2019, USD 806.7m was invested in Korean private biotech companies that accounted for almost 4% of the total global biotech financing amount. The country currently offers hundreds of biotech and medtech assets to out-licence. We would like to thank our … Continue reading Korean Life Science Market Trend Analysis 2020
South Korean Life Sciences Trend Analysis 2015
South Korea has become an important player in the Biotech and Life Sciences space. Click here to download South Korean Life Sciences Trend Analysis 2013 – 11 pages Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new leads, licensing opportunities and management details. Get started now Learn more
South Korean Life Sciences Trend Analysis 2013
Financing value in South Korean Biotech (Therapeutics & Diagnostics) in 2013 more than doubled that of 2012, reaching a historical high value of 21.7 billion KRW (23.7 million USD). Click here to download South Korean Life Sciences Trend Analysis 2013 – 12 pages